Breast Cancer, Male - 25 Studies Found

Active, not recruiting : Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Biological: cixutumumab Given

Completed : A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Drug: cediranib maleate Given

Terminated : Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Drug: vorinostat Given PO
Completed : FR901228 in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Drug: romidepsin Given IV
Completed : Sorafenib in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Drug: sorafenib tosylate Given
Terminated : 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Drug: triapine Given IV

Terminated : Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Biological: recombinant vaccinia-MUC1 vaccine

Completed : GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Biological: GTI-2040 Given IV
Completed : Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Drug: imatinib mesylate Given

Completed : Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Biological: trastuzumab Given

<<< Previous | Next >>>